Explore more publications!
Nepal Healthcare Times
Got News to Share?

Nepal Healthcare Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nepal Healthcare Times.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 23, 2025

Best BPC-157 Oral Supplements: ProHealth's Triple-Tested Formula Examined as Peptide Quality Verification Becomes Consumer Priority Heading Into 2026
December 23, 2025

Best BPC-157 Oral Supplements: ProHealth's Triple-Tested Formula Examined as Peptide Quality Verification Becomes Consumer Priority Heading Into 2026

Indeterminate GlobeNewswire
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn
December 23, 2025

Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn

Indeterminate GlobeNewswire
Novarad Unveils MammoIQ, a Comprehensive Breast Imaging Platform Built for the Advanced Digital Era
December 23, 2025

Novarad Unveils MammoIQ, a Comprehensive Breast Imaging Platform Built for the Advanced Digital Era

Indeterminate GlobeNewswire
Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change
December 23, 2025

Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change

Indeterminate GlobeNewswire
Organogenesis Announces Initiation of Biologics License Application for ReNu®
December 23, 2025

Organogenesis Announces Initiation of Biologics License Application for ReNu®

Indeterminate GlobeNewswire
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors
December 23, 2025

Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors

Indeterminate GlobeNewswire
Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche
December 23, 2025

Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche

Indeterminate GlobeNewswire
On the Anniversary of the World's First Successful Kidney Transplant, Renown Transplant Institute Celebrates Second and Third Successful Transplants
December 23, 2025

On the Anniversary of the World's First Successful Kidney Transplant, Renown Transplant Institute Celebrates Second and Third Successful Transplants

Indeterminate GlobeNewswire
Singlera Genomics Signs European Distribution and Research Agreement with Pure Medical for Cancer Detection Products
December 23, 2025

Singlera Genomics Signs European Distribution and Research Agreement with Pure Medical for Cancer Detection Products

Indeterminate GlobeNewswire
Sequana Medical announces execution of letter of intent to amend terms of the Kreos Loan
December 23, 2025

Sequana Medical announces execution of letter of intent to amend terms of the Kreos Loan

Indeterminate GlobeNewswire
Qualifacts and Richstone Center Partner to Modernize Trauma-Informed Care Across Los Angeles County
December 23, 2025

Qualifacts and Richstone Center Partner to Modernize Trauma-Informed Care Across Los Angeles County

Indeterminate GlobeNewswire
ABC Calls on Congress to Act Now to Modernize Blood Center Regulations
December 23, 2025

ABC Calls on Congress to Act Now to Modernize Blood Center Regulations

Indeterminate GlobeNewswire
Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure
December 23, 2025

Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure

Indeterminate GlobeNewswire
Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
December 23, 2025

Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia

Indeterminate GlobeNewswire
Communiqué de presse : Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI)
December 23, 2025

Communiqué de presse : Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI)

Indeterminate GlobeNewswire
Merit Medical to Participate at the J.P. Morgan Healthcare Conference
December 23, 2025

Merit Medical to Participate at the J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Kailera Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
December 23, 2025

Kailera Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
J-Star’s LITZMO Introduces ER-01: The Brand’s First Carbon Fiber Fat-Tire E‑Assist Bicycle
December 23, 2025

J-Star’s LITZMO Introduces ER-01: The Brand’s First Carbon Fiber Fat-Tire E‑Assist Bicycle

Indeterminate GlobeNewswire
Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc.
December 23, 2025

Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc.

Indeterminate GlobeNewswire
MAPS Supports Therapy Education for First-Ever Department of Defense-Affiliated MDMA-Assisted Therapy Pilot
December 23, 2025

MAPS Supports Therapy Education for First-Ever Department of Defense-Affiliated MDMA-Assisted Therapy Pilot

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions